Vivo Opportunity Fund Holdings, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value (CDTX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
CDTX
Shares outstanding
13,027,149 shares
Disclosed Ownership
612,276 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 08:31:03 UTC
Date of event
31 Mar 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 4.7% 612,276 612,276 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity, LLC 4.7% 612,276 612,276 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.6% 72,000 72,000 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman, LLC 0.6% 72,000 72,000 0 /s/ Kevin Dai Kevin Dai/Managing Member